United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization

yf_tkr_UTHR · 2026-10-22

$UTHR $BGHL

SILVER SPRING, M.D. & RESEARCH TRIANGLE PARK, N.C., October 22, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors has authorized a new share repurchase program for up to $2 billion of the company’s common stock, available through October 21, 2027.

Sector coverage: Healthcare · Drug Manufacturers - Specialty & Generic · Consumer Defensive · Food and Kindred Products

Read the original at yf_tkr_UTHR ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.